Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

The inconvincible patient: how clinicians perceive demand for antibiotics in the outpatient setting.

Kohut MR, Keller SC, Linder JA, Tamma PD, Cosgrove SE, Speck K, Ahn R, Dullabh P, Miller MA, Szymczak JE.

Fam Pract. 2019 Nov 6. pii: cmz066. doi: 10.1093/fampra/cmz066. [Epub ahead of print]

PMID:
31690948
2.

Research needs in antibiotic stewardship.

Morris AM, Calderwood MS, Fridkin SK, Livorsi DJ, McGregor JC, Mody L, Moehring RW, Pakyz AL, Stenehjem E, Szymczak JE, Tamma PD.

Infect Control Hosp Epidemiol. 2019 Dec;40(12):1334-1343. doi: 10.1017/ice.2019.276. Epub 2019 Oct 30. No abstract available.

PMID:
31662139
3.

Things We Do for No Reason: Lumbar Punctures in Low-Risk Febrile Infants with Bronchiolitis.

Berk J, Biondi E, Tamma PD, Herzke C.

J Hosp Med. 2019 Oct 23;14:E1-E3. doi: 10.12788/jhm.3317. [Epub ahead of print] No abstract available.

PMID:
31634097
4.

Impact of an Antibiotic Stewardship Program on the Incidence of Vancomycin-Associated Acute Kidney Injury in Hospitalized Children.

Hsu AJ, Tamma PD.

J Pediatr Pharmacol Ther. 2019 Sep-Oct;24(5):416-420. doi: 10.5863/1551-6776-24.5.416.

5.

Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs.

Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ.

J Clin Microbiol. 2019 Nov 22;57(12). pii: e01127-19. doi: 10.1128/JCM.01127-19. Print 2019 Dec.

PMID:
31597748
6.

Imported Cases of Extensively Drug-Resistant Salmonella.

Simner PJ, Bergman Y, Tamma PD.

Pediatr Infect Dis J. 2019 Dec;38(12):e340. doi: 10.1097/INF.0000000000002450. No abstract available.

PMID:
31469779
7.

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections in Children: Translating Evidence From Adults Into Pediatric Practice.

Same RG, Hsu AJ, Tamma PD.

J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):485-488. doi: 10.1093/jpids/piz051. No abstract available.

PMID:
31436812
8.

Admission Laboratory Values Accurately Predict In-hospital Mortality: a Retrospective Cohort Study.

Blanco N, Leekha S, Magder L, Jackson SS, Tamma PD, Lemkin D, Harris AD.

J Gen Intern Med. 2019 Aug 20. doi: 10.1007/s11606-019-05282-2. [Epub ahead of print]

PMID:
31432440
9.

Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States.

Tamma PD, Shahara SL, Pana ZD, Amoah J, Fisher SL, Tekle T, Doi Y, Simner PJ.

Open Forum Infect Dis. 2019 Aug 11;6(8). pii: ofz353. doi: 10.1093/ofid/ofz353.

10.

The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during a Hospital Stay.

Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00757-19. doi: 10.1128/AAC.00757-19. Print 2019 Aug.

PMID:
31138574
11.

Antibiotic stewardship in the intensive care unit: Challenges and opportunities.

Chiotos K, Tamma PD, Gerber JS.

Infect Control Hosp Epidemiol. 2019 Jun;40(6):693-698. doi: 10.1017/ice.2019.74. Epub 2019 May 3.

PMID:
31046851
12.

Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Toerper MF, Levin S, Tamma PD, Rock C, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2019 May;40(5):541-550. doi: 10.1017/ice.2019.42. Epub 2019 Mar 27.

PMID:
30915928
13.

Reporting Extended-Spectrum β-Lactamase Positivity May Reduce Carbapenem Overuse.

Tamma PD, Cosgrove SE, Avdic E, Carroll KC, Simner PJ.

Open Forum Infect Dis. 2019 Feb 19;6(3):ofz064. doi: 10.1093/ofid/ofz064. eCollection 2019 Mar. No abstract available.

14.

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Fabre V, Amoah J, Cosgrove SE, Tamma PD.

Clin Infect Dis. 2019 Nov 13;69(11):2011-2014. doi: 10.1093/cid/ciz223.

PMID:
30882137
15.

A Novel Phenotypic Method To Screen for Plasmid-Mediated Colistin Resistance among Enterobacteriales.

Bell DT, Bergman Y, Kazmi AQ, Lewis S, Tamma PD, Simner PJ.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00040-19. doi: 10.1128/JCM.00040-19. Print 2019 May.

16.

A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ; Antibacterial Resistance Leadership Group .

Clin Infect Dis. 2019 Sep 27;69(8):1446-1455. doi: 10.1093/cid/ciz173.

PMID:
30838380
17.

A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia.

Goodman KE, Lessler J, Harris AD, Milstone AM, Tamma PD.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):400-407. doi: 10.1017/ice.2019.17. Epub 2019 Mar 4.

PMID:
30827286
18.

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.

Tamma PD, Hsu AJ.

J Pediatric Infect Dis Soc. 2019 Jul 1;8(3):251-260. doi: 10.1093/jpids/piz002.

PMID:
30793757
19.

Integrating bedside nurses into antibiotic stewardship: A practical approach.

Monsees EA, Tamma PD, Cosgrove SE, Miller MA, Fabre V.

Infect Control Hosp Epidemiol. 2019 May;40(5):579-584. doi: 10.1017/ice.2018.362. Epub 2019 Feb 21.

PMID:
30786944
20.

Association of a blood culture utilization intervention on antibiotic use in a pediatric intensive care unit.

Sick-Samuels AC, Woods-Hill CZ, Fackler JC, Tamma PD, Klaus SA, Colantuoni EE, Milstone AM.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):482-484. doi: 10.1017/ice.2019.10. Epub 2019 Feb 15.

21.

A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.

Sick-Samuels AC, Goodman KE, Rapsinski G, Colantouni E, Milstone AM, Nowalk AJ, Tamma PD.

J Pediatric Infect Dis Soc. 2019 Jan 25. doi: 10.1093/jpids/piy137. [Epub ahead of print]

PMID:
30690525
22.

Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

Tamma PD, Conley AT, Cosgrove SE, Harris AD, Lautenbach E, Amoah J, Avdic E, Tolomeo P, Wise J, Subudhi S, Han JH; Antibacterial Resistance Leadership Group.

JAMA Intern Med. 2019 Mar 1;179(3):316-323. doi: 10.1001/jamainternmed.2018.6226. Erratum in: JAMA Intern Med. 2019 Nov 1;179(11):1607.

PMID:
30667477
23.

The Role of Ertapenem for the Treatment of Complicated Intra-abdominal Infections With a Positive Culture for Enterococcus faecalis.

Fabre V, Nemati K, Avdic E, Cosgrove SE, Amoah J, Tamma PD.

Open Forum Infect Dis. 2018 Dec 15;6(1):ofy339. doi: 10.1093/ofid/ofy339. eCollection 2019 Jan.

24.

Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making Into Clinical Practice.

Tamma PD, Miller MA, Cosgrove SE.

JAMA. 2019 Jan 15;321(2):139-140. doi: 10.1001/jama.2018.19509. No abstract available.

PMID:
30589917
25.

Impact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients.

Thom KA, Tamma PD, Harris AD, Dzintars K, Morgan DJ, Li S, Pineles L, Srinivasan A, Avdic E, Cosgrove SE.

Clin Infect Dis. 2019 Apr 24;68(9):1581-1584. doi: 10.1093/cid/ciy852.

PMID:
30517592
26.

Campylobacter Infections in Children.

Same RG, Tamma PD.

Pediatr Rev. 2018 Nov;39(11):533-541. doi: 10.1542/pir.2017-0285. Review. No abstract available.

27.

Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates.

Tamma PD, Fan Y, Bergman Y, Pertea G, Kazmi AQ, Lewis S, Carroll KC, Schatz MC, Timp W, Simner PJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01923-18. doi: 10.1128/AAC.01923-18. Print 2019 Jan.

28.

The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria.

Plazak ME, Tamma PD, Heil EL.

Expert Opin Pharmacother. 2018 Dec;19(18):2019-2031. doi: 10.1080/14656566.2018.1538354. Epub 2018 Nov 5. Review.

PMID:
30346216
29.

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children.

Chiotos K, Tamma PD, Flett KB, Karandikar MV, Nemati K, Bilker WB, Zaoutis T, Han JH.

Open Forum Infect Dis. 2018 Sep 10;5(10):ofy222. doi: 10.1093/ofid/ofy222. eCollection 2018 Oct.

30.

Two-Site Evaluation of the Colistin Broth Disk Elution Test To Determine Colistin In Vitro Activity against Gram-Negative Bacilli.

Simner PJ, Bergman Y, Trejo M, Roberts AA, Marayan R, Tekle T, Campeau S, Kazmi AQ, Bell DT, Lewis S, Tamma PD, Humphries R, Hindler JA.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01163-18. doi: 10.1128/JCM.01163-18. Print 2019 Feb.

31.

How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?

Goodman KE, Simner PJ, Klein EY, Kazmi AQ, Gadala A, Rock C, Tamma PD, Cosgrove SE, Maragakis LL, Milstone AM; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1491-1493. doi: 10.1017/ice.2018.236. Epub 2018 Oct 1.

32.

Single Academic Center Experience of Unrestricted β-d-Glucan Implementation.

Fabre V, Markou T, DeMallie K, Mehta S, Shoham S, Tamma PD, Zhang S, Cosgrove SE.

Open Forum Infect Dis. 2018 Aug 9;5(9):ofy195. doi: 10.1093/ofid/ofy195. eCollection 2018 Sep.

33.

Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.

Tamma PD, Simner PJ.

J Clin Microbiol. 2018 Oct 25;56(11). pii: e01140-18. doi: 10.1128/JCM.01140-18. Print 2018 Nov. Review.

34.

Increasing Clindamycin and Trimethoprim-Sulfamethoxazole Resistance in Pediatric Staphylococcus aureus Infections.

Khamash DF, Voskertchian A, Tamma PD, Akinboyo IC, Carroll KC, Milstone AM.

J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):351-353. doi: 10.1093/jpids/piy062.

PMID:
30011009
35.

Can the Ceftriaxone Breakpoints Be Increased Without Compromising Patient Outcomes?

Tamma PD, Pierce VM, Cosgrove SE, Lautenbach E, Harris A, Rayapati D, Han JH.

Open Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139. eCollection 2018 Jun.

36.

Using Patient Risk Factors to Identify Whether Carbapenem-Resistant Enterobacteriaceae Infections Are Caused by Carbapenemase-Producing Organisms.

Simner PJ, Goodman KE, Carroll KC, Harris AD, Han JH, Tamma PD.

Open Forum Infect Dis. 2018 May 17;5(5):ofy094. doi: 10.1093/ofid/ofy094. eCollection 2018 May.

37.

Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review.

Keller SC, Tamma PD, Cosgrove SE, Miller MA, Sateia H, Szymczak J, Gurses AP, Linder JA.

J Am Board Fam Med. 2018 May-Jun;31(3):417-430. doi: 10.3122/jabfm.2018.03.170225.

38.

Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.

Simner PJ, Antar AAR, Hao S, Gurtowski J, Tamma PD, Rock C, Opene BNA, Tekle T, Carroll KC, Schatz MC, Timp W.

J Antimicrob Chemother. 2018 Jul 1;73(7):1796-1803. doi: 10.1093/jac/dky121.

39.

Reply to Chou and Trautner.

Chotiprasitakul D, Han JH, Lautenbach E, Cosgrove SE, Harris AD, Tamma PD.

Clin Infect Dis. 2018 Jul 18;67(3):483. doi: 10.1093/cid/ciy118. No abstract available.

PMID:
29617738
40.

Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting.

Doernberg SB, Abbo LM, Burdette SD, Fishman NO, Goodman EL, Kravitz GR, Leggett JE, Moehring RW, Newland JG, Robinson PA, Spivak ES, Tamma PD, Chambers HF.

Clin Infect Dis. 2018 Sep 28;67(8):1168-1174. doi: 10.1093/cid/ciy255.

PMID:
29590355
41.

Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.

Tamma PD, Fan Y, Bergman Y, Sick-Samuels AC, Hsu AJ, Timp W, Simner PJ, Prokesch BC, Greenberg DE.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02213-17. doi: 10.1128/AAC.02213-17. Print 2018 Apr.

42.

Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.

Smith TT, Tamma PD, Do TB, Dzintars KE, Zhao Y, Cosgrove SE, Avdic E.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):161-163. doi: 10.1016/j.diagmicrobio.2018.01.027. Epub 2018 Feb 3.

PMID:
29496381
43.

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.

Chotiprasitsakul D, Tamma PD, Gadala A, Cosgrove SE.

Infect Control Hosp Epidemiol. 2018 Mar;39(3):290-296. doi: 10.1017/ice.2017.308. Epub 2018 Jan 28.

PMID:
29374504
44.

Reply to Al-Hasan et al.

Chotiprasitakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Tamma PD.

Clin Infect Dis. 2018 Jun 1;66(12):1979-1981. doi: 10.1093/cid/ciy046. No abstract available.

PMID:
29365075
45.

Expanding Existing Antimicrobial Stewardship Programs in Pediatrics: What Comes Next.

Kronman MP, Banerjee R, Duchon J, Gerber JS, Green MD, Hersh AL, Hyun D, Maples H, Nash CB, Parker S, Patel SJ, Saiman L, Tamma PD, Newland JG.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):241-248. doi: 10.1093/jpids/pix104. Review.

PMID:
29267871
46.

Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms.

Schuetz AN, Reyes S, Tamma PD.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01917-17. doi: 10.1128/JCM.01917-17. Print 2018 Mar. Review.

47.

Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Carriage Upon Pediatric Intensive Care Unit Admission.

Li DX, Sick-Samuels AC, Suwantarat N, Same RG, Simner PJ, Tamma PD.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):116-118. doi: 10.1017/ice.2017.246. Epub 2017 Dec 5. No abstract available.

48.

Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort.

Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT, Tolomeo P, Wise J, Tamma PD; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2018 Jan 6;66(2):172-177. doi: 10.1093/cid/cix767.

49.

Implementing Antimicrobial Stewardship in Long-term Care Settings: An Integrative Review Using a Human Factors Approach.

Katz MJ, Gurses AP, Tamma PD, Cosgrove SE, Miller MA, Jump RLP.

Clin Infect Dis. 2017 Nov 13;65(11):1943-1951. doi: 10.1093/cid/cix566. Review.

50.

Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.

Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, Hersh AL, Tamma PD.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):338-341. doi: 10.1093/jpids/pix068.

PMID:
28992126

Supplemental Content

Loading ...
Support Center